Literature DB >> 9083582

Differential immune response to Onchocerca volvulus: IgG4 antibody responses differ in onchocerciasis patients from Guatemala and Ghana.

G E Guzmán1, H O Akuffo, C Lavebratt, R Luján.   

Abstract

Geographical differences exist in the clinical features of onchocerciasis in Central America and West Africa, which could be due in part from variations in the antigenic composition of the infecting organism. In an attempt to address this question, adult female worms of Onchocerca volvulus derived from nodules of patients from Guatemala and Ghana were compared in terms of polypeptide composition and the IgG4 antibody responses induced in patients. It was shown that a Tris-buffer soluble extract from the worms obtained in the two regions differ in polypeptide composition. Furthermore, the diagnostic polypeptides were found to be in the 30 kDa region but the recognition of these antigens was less intense and less frequently observed in the sera of microfilaria (mf) positive patients from Ghana than equivalent age and sex matched patients from Guatemala.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083582     DOI: 10.1016/s0001-706x(96)00613-4

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  3 in total

1.  Prevalence of antibodies to onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin.

Authors:  Alberto Gómez-Priego; Raymundo Mendoza; Jorge-Luis de-la-Rosa
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

2.  Comparison between the skin snip test and simple dot blot assay as potential rapid assessment tools for Onchocerciasis in the postcontrol era in Ghana.

Authors:  G E Guzmán; K Awadzi; N Opoku; R B Narayanan; H O Akuffo
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

3.  Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindness.

Authors:  Daniel Globisch; Amira Y Moreno; Mark S Hixon; Ashlee A K Nunes; Judith R Denery; Sabine Specht; Achim Hoerauf; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.